Cingulate Inc. Warrants Share Price
NASDAQ: CINGW | Micro CapCingulate Inc. Warrants Stock Performance
Cingulate Inc. Warrants Share Price Chart
Cingulate Inc. Warrants Quarterly Profit & Loss
All figures in USD
Cingulate Inc. Warrants Annual Profit & Loss
All figures in USD
About Cingulate Inc. Warrants
Cingulate Inc is a clinical-stage biopharmaceutical company focused on the development of products utilizing its drug delivery platform technology that enables the formulation and manufacture of once-daily tablets of multi-dose therapies, with an initial focus on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety. The Company is developing two proprietary, first-line stimulant medications, CTx-1301 (dexmethylphenidate) and CTx-1302 (dextroamphetamine), for the treatment of ADHD intended for all patient segments: children, adolescents, and adults. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.
Cingulate Inc. Warrants Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $0.01 | $0.01 | -83.67% |
Feb 2026 | $0.07 | $0.05 | -2.00% |
Jan 2026 | $0.05 | $0.05 | -37.50% |
Dec 2025 | $0.08 | $0.08 | +60.00% |
Oct 2025 | $0.05 | $0.05 | +0.00% |
Aug 2025 | $0.06 | $0.05 | -21.87% |
Jul 2025 | $0.06 | $0.06 | +0.00% |
Jun 2025 | $0.04 | $0.06 | +16.36% |
May 2025 | $0.04 | $0.06 | +25.00% |
Apr 2025 | $0.06 | $0.04 | -16.98% |
Mar 2025 | $0.04 | $0.05 | +32.50% |
Feb 2025 | $0.06 | $0.04 | -37.50% |